Compare ORI & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ORI | RGEN |
|---|---|---|
| Founded | 1923 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.9B | 8.1B |
| IPO Year | 1994 | 1995 |
| Metric | ORI | RGEN |
|---|---|---|
| Price | $40.34 | $116.47 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 11 |
| Target Price | $42.50 | ★ $175.64 |
| AVG Volume (30 Days) | ★ 1.4M | 865.9K |
| Earning Date | 04-23-2026 | 04-28-2026 |
| Dividend Yield | ★ 9.06% | N/A |
| EPS Growth | 14.81 | ★ 286.96 |
| EPS | ★ 3.72 | 0.86 |
| Revenue | ★ $9,136,300,000.00 | $141,236,000.00 |
| Revenue This Year | $7.07 | $14.30 |
| Revenue Next Year | $6.86 | $14.52 |
| P/E Ratio | ★ $10.87 | $137.02 |
| Revenue Growth | 10.99 | ★ 35.10 |
| 52 Week Low | $34.43 | $102.97 |
| 52 Week High | $46.76 | $175.77 |
| Indicator | ORI | RGEN |
|---|---|---|
| Relative Strength Index (RSI) | 51.77 | 44.35 |
| Support Level | $38.75 | $112.53 |
| Resistance Level | $43.54 | $131.81 |
| Average True Range (ATR) | 0.84 | 4.75 |
| MACD | 0.17 | 1.32 |
| Stochastic Oscillator | 83.03 | 62.65 |
Old Republic International Corp is engaged in the business of insurance underwriting and related services. The company operates in two segments: Specialty Insurance and Title Insurance. The insurance provided by the company includes Automobile Extended Warranty Insurance, Aviation, Commercial Automobile Insurance, Inland Marine, Travel Accident, Workers' Compensation, Financial Indemnity, and others. The company generates the majority of its revenue from Specialty Insurance. The Specialty Insurance provides property and liability insurance principally to commercial clients.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.